カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のPECAM-1抗体市場2022年：ネズミ、ウナギ、その他

◆英語タイトル：Global PECAM-1 Antibody Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY8928）◆商品コード：GIR22MY8928
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：129
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

PECAM-1抗体市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のPECAM-1抗体の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

PECAM-1抗体市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ネズミ、ウナギ、その他

用途別セグメントは次のように区分されます。
・研究室、病院、その他

世界のPECAM-1抗体市場の主要な市場プレーヤーは以下のとおりです。
・Thermo Fisher、MilliporeSigma、Abcam、BioLegend、Novus Biologicals、Dianova、Santa Cruz Biotechnology、Proteintech Group、R&D Systems、Miltenyi Biotec、Bio-Rad、LifeSpan Biosciences、Abnova、OriGene、SICGEN、YO Proteins、Enzo Life Sciences、Boster、Abeomics、Rockland Immunochemicals、Bon Opus Biosciences、Creative Biomart、US Biological

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、PECAM-1抗体製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なPECAM-1抗体メーカーの企業概要、2019年～2022年までのPECAM-1抗体の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なPECAM-1抗体メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別PECAM-1抗体の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのPECAM-1抗体の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのPECAM-1抗体市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびPECAM-1抗体の産業チェーンを掲載しています。
・第13、14、15章では、PECAM-1抗体の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Thermo Fisher、MilliporeSigma、Abcam、BioLegend、Novus Biologicals、Dianova、Santa Cruz Biotechnology、Proteintech Group、R&D Systems、Miltenyi Biotec、Bio-Rad、LifeSpan Biosciences、Abnova、OriGene、SICGEN、YO Proteins、Enzo Life Sciences、Boster、Abeomics、Rockland Immunochemicals、Bon Opus Biosciences、Creative Biomart、US Biological
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ネズミ、ウナギ、その他
・用途別分析2017年-2028年：研究室、病院、その他
・PECAM-1抗体の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・PECAM-1抗体のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・PECAM-1抗体のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・PECAM-1抗体の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・PECAM-1抗体の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The PECAM-1 Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global PECAM-1 Antibody market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Laboratory accounting for % of the PECAM-1 Antibody global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Mouse segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of PECAM-1 Antibody include Thermo Fisher, MilliporeSigma, Abcam, BioLegend, and Novus Biologicals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
PECAM-1 Antibody market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Mouse
Rabbit
Others
Market segment by Application can be divided into
Laboratory
Hospital
Others
The key market players for global PECAM-1 Antibody market are listed below:
Thermo Fisher
MilliporeSigma
Abcam
BioLegend
Novus Biologicals
Dianova
Santa Cruz Biotechnology
Proteintech Group
R&D Systems
Miltenyi Biotec
Bio-Rad
LifeSpan Biosciences
Abnova
OriGene
SICGEN
YO Proteins
Enzo Life Sciences
Boster
Abeomics
Rockland Immunochemicals
Bon Opus Biosciences
Creative Biomart
US Biological
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PECAM-1 Antibody product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of PECAM-1 Antibody, with price, sales, revenue and global market share of PECAM-1 Antibody from 2019 to 2022.
Chapter 3, the PECAM-1 Antibody competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PECAM-1 Antibody breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and PECAM-1 Antibody market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of PECAM-1 Antibody.
Chapter 13, 14, and 15, to describe PECAM-1 Antibody sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 PECAM-1 Antibody Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global PECAM-1 Antibody Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Mouse
1.2.3 Rabbit
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global PECAM-1 Antibody Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Laboratory
1.3.3 Hospital
1.3.4 Others
1.4 Global PECAM-1 Antibody Market Size & Forecast
1.4.1 Global PECAM-1 Antibody Sales in Value (2017 & 2021 & 2028)
1.4.2 Global PECAM-1 Antibody Sales in Volume (2017-2028)
1.4.3 Global PECAM-1 Antibody Price (2017-2028)
1.5 Global PECAM-1 Antibody Production Capacity Analysis
1.5.1 Global PECAM-1 Antibody Total Production Capacity (2017-2028)
1.5.2 Global PECAM-1 Antibody Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 PECAM-1 Antibody Market Drivers
1.6.2 PECAM-1 Antibody Market Restraints
1.6.3 PECAM-1 Antibody Trends Analysis
2 Manufacturers Profiles
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher PECAM-1 Antibody Product and Services
2.1.4 Thermo Fisher PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 MilliporeSigma
2.2.1 MilliporeSigma Details
2.2.2 MilliporeSigma Major Business
2.2.3 MilliporeSigma PECAM-1 Antibody Product and Services
2.2.4 MilliporeSigma PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Abcam
2.3.1 Abcam Details
2.3.2 Abcam Major Business
2.3.3 Abcam PECAM-1 Antibody Product and Services
2.3.4 Abcam PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 BioLegend
2.4.1 BioLegend Details
2.4.2 BioLegend Major Business
2.4.3 BioLegend PECAM-1 Antibody Product and Services
2.4.4 BioLegend PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Novus Biologicals
2.5.1 Novus Biologicals Details
2.5.2 Novus Biologicals Major Business
2.5.3 Novus Biologicals PECAM-1 Antibody Product and Services
2.5.4 Novus Biologicals PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Dianova
2.6.1 Dianova Details
2.6.2 Dianova Major Business
2.6.3 Dianova PECAM-1 Antibody Product and Services
2.6.4 Dianova PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Santa Cruz Biotechnology
2.7.1 Santa Cruz Biotechnology Details
2.7.2 Santa Cruz Biotechnology Major Business
2.7.3 Santa Cruz Biotechnology PECAM-1 Antibody Product and Services
2.7.4 Santa Cruz Biotechnology PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Proteintech Group
2.8.1 Proteintech Group Details
2.8.2 Proteintech Group Major Business
2.8.3 Proteintech Group PECAM-1 Antibody Product and Services
2.8.4 Proteintech Group PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 R&D Systems
2.9.1 R&D Systems Details
2.9.2 R&D Systems Major Business
2.9.3 R&D Systems PECAM-1 Antibody Product and Services
2.9.4 R&D Systems PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Miltenyi Biotec
2.10.1 Miltenyi Biotec Details
2.10.2 Miltenyi Biotec Major Business
2.10.3 Miltenyi Biotec PECAM-1 Antibody Product and Services
2.10.4 Miltenyi Biotec PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Bio-Rad
2.11.1 Bio-Rad Details
2.11.2 Bio-Rad Major Business
2.11.3 Bio-Rad PECAM-1 Antibody Product and Services
2.11.4 Bio-Rad PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 LifeSpan Biosciences
2.12.1 LifeSpan Biosciences Details
2.12.2 LifeSpan Biosciences Major Business
2.12.3 LifeSpan Biosciences PECAM-1 Antibody Product and Services
2.12.4 LifeSpan Biosciences PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Abnova
2.13.1 Abnova Details
2.13.2 Abnova Major Business
2.13.3 Abnova PECAM-1 Antibody Product and Services
2.13.4 Abnova PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 OriGene
2.14.1 OriGene Details
2.14.2 OriGene Major Business
2.14.3 OriGene PECAM-1 Antibody Product and Services
2.14.4 OriGene PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 SICGEN
2.15.1 SICGEN Details
2.15.2 SICGEN Major Business
2.15.3 SICGEN PECAM-1 Antibody Product and Services
2.15.4 SICGEN PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 YO Proteins
2.16.1 YO Proteins Details
2.16.2 YO Proteins Major Business
2.16.3 YO Proteins PECAM-1 Antibody Product and Services
2.16.4 YO Proteins PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Enzo Life Sciences
2.17.1 Enzo Life Sciences Details
2.17.2 Enzo Life Sciences Major Business
2.17.3 Enzo Life Sciences PECAM-1 Antibody Product and Services
2.17.4 Enzo Life Sciences PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Boster
2.18.1 Boster Details
2.18.2 Boster Major Business
2.18.3 Boster PECAM-1 Antibody Product and Services
2.18.4 Boster PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Abeomics
2.19.1 Abeomics Details
2.19.2 Abeomics Major Business
2.19.3 Abeomics PECAM-1 Antibody Product and Services
2.19.4 Abeomics PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Rockland Immunochemicals
2.20.1 Rockland Immunochemicals Details
2.20.2 Rockland Immunochemicals Major Business
2.20.3 Rockland Immunochemicals PECAM-1 Antibody Product and Services
2.20.4 Rockland Immunochemicals PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Bon Opus Biosciences
2.21.1 Bon Opus Biosciences Details
2.21.2 Bon Opus Biosciences Major Business
2.21.3 Bon Opus Biosciences PECAM-1 Antibody Product and Services
2.21.4 Bon Opus Biosciences PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 Creative Biomart
2.22.1 Creative Biomart Details
2.22.2 Creative Biomart Major Business
2.22.3 Creative Biomart PECAM-1 Antibody Product and Services
2.22.4 Creative Biomart PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23 US Biological
2.23.1 US Biological Details
2.23.2 US Biological Major Business
2.23.3 US Biological PECAM-1 Antibody Product and Services
2.23.4 US Biological PECAM-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 PECAM-1 Antibody Breakdown Data by Manufacturer
3.1 Global PECAM-1 Antibody Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global PECAM-1 Antibody Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in PECAM-1 Antibody
3.4 Market Concentration Rate
3.4.1 Top 3 PECAM-1 Antibody Manufacturer Market Share in 2021
3.4.2 Top 6 PECAM-1 Antibody Manufacturer Market Share in 2021
3.5 Global PECAM-1 Antibody Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and PECAM-1 Antibody Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global PECAM-1 Antibody Market Size by Region
4.1.1 Global PECAM-1 Antibody Sales in Volume by Region (2017-2028)
4.1.2 Global PECAM-1 Antibody Revenue by Region (2017-2028)
4.2 North America PECAM-1 Antibody Revenue (2017-2028)
4.3 Europe PECAM-1 Antibody Revenue (2017-2028)
4.4 Asia-Pacific PECAM-1 Antibody Revenue (2017-2028)
4.5 South America PECAM-1 Antibody Revenue (2017-2028)
4.6 Middle East and Africa PECAM-1 Antibody Revenue (2017-2028)
5 Market Segment by Type
5.1 Global PECAM-1 Antibody Sales in Volume by Type (2017-2028)
5.2 Global PECAM-1 Antibody Revenue by Type (2017-2028)
5.3 Global PECAM-1 Antibody Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global PECAM-1 Antibody Sales in Volume by Application (2017-2028)
6.2 Global PECAM-1 Antibody Revenue by Application (2017-2028)
6.3 Global PECAM-1 Antibody Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America PECAM-1 Antibody Sales by Type (2017-2028)
7.2 North America PECAM-1 Antibody Sales by Application (2017-2028)
7.3 North America PECAM-1 Antibody Market Size by Country
7.3.1 North America PECAM-1 Antibody Sales in Volume by Country (2017-2028)
7.3.2 North America PECAM-1 Antibody Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe PECAM-1 Antibody Sales by Type (2017-2028)
8.2 Europe PECAM-1 Antibody Sales by Application (2017-2028)
8.3 Europe PECAM-1 Antibody Market Size by Country
8.3.1 Europe PECAM-1 Antibody Sales in Volume by Country (2017-2028)
8.3.2 Europe PECAM-1 Antibody Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific PECAM-1 Antibody Sales by Type (2017-2028)
9.2 Asia-Pacific PECAM-1 Antibody Sales by Application (2017-2028)
9.3 Asia-Pacific PECAM-1 Antibody Market Size by Region
9.3.1 Asia-Pacific PECAM-1 Antibody Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific PECAM-1 Antibody Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America PECAM-1 Antibody Sales by Type (2017-2028)
10.2 South America PECAM-1 Antibody Sales by Application (2017-2028)
10.3 South America PECAM-1 Antibody Market Size by Country
10.3.1 South America PECAM-1 Antibody Sales in Volume by Country (2017-2028)
10.3.2 South America PECAM-1 Antibody Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa PECAM-1 Antibody Sales by Type (2017-2028)
11.2 Middle East & Africa PECAM-1 Antibody Sales by Application (2017-2028)
11.3 Middle East & Africa PECAM-1 Antibody Market Size by Country
11.3.1 Middle East & Africa PECAM-1 Antibody Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa PECAM-1 Antibody Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of PECAM-1 Antibody and Key Manufacturers
12.2 Manufacturing Costs Percentage of PECAM-1 Antibody
12.3 PECAM-1 Antibody Production Process
12.4 PECAM-1 Antibody Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 PECAM-1 Antibody Typical Distributors
13.3 PECAM-1 Antibody Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global PECAM-1 Antibody Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global PECAM-1 Antibody Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 4. Thermo Fisher Major Business
Table 5. Thermo Fisher PECAM-1 Antibody Product and Services
Table 6. Thermo Fisher PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. MilliporeSigma Basic Information, Manufacturing Base and Competitors
Table 8. MilliporeSigma Major Business
Table 9. MilliporeSigma PECAM-1 Antibody Product and Services
Table 10. MilliporeSigma PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Abcam Basic Information, Manufacturing Base and Competitors
Table 12. Abcam Major Business
Table 13. Abcam PECAM-1 Antibody Product and Services
Table 14. Abcam PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. BioLegend Basic Information, Manufacturing Base and Competitors
Table 16. BioLegend Major Business
Table 17. BioLegend PECAM-1 Antibody Product and Services
Table 18. BioLegend PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Novus Biologicals Basic Information, Manufacturing Base and Competitors
Table 20. Novus Biologicals Major Business
Table 21. Novus Biologicals PECAM-1 Antibody Product and Services
Table 22. Novus Biologicals PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Dianova Basic Information, Manufacturing Base and Competitors
Table 24. Dianova Major Business
Table 25. Dianova PECAM-1 Antibody Product and Services
Table 26. Dianova PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Santa Cruz Biotechnology Basic Information, Manufacturing Base and Competitors
Table 28. Santa Cruz Biotechnology Major Business
Table 29. Santa Cruz Biotechnology PECAM-1 Antibody Product and Services
Table 30. Santa Cruz Biotechnology PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Proteintech Group Basic Information, Manufacturing Base and Competitors
Table 32. Proteintech Group Major Business
Table 33. Proteintech Group PECAM-1 Antibody Product and Services
Table 34. Proteintech Group PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. R&D Systems Basic Information, Manufacturing Base and Competitors
Table 36. R&D Systems Major Business
Table 37. R&D Systems PECAM-1 Antibody Product and Services
Table 38. R&D Systems PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Miltenyi Biotec Basic Information, Manufacturing Base and Competitors
Table 40. Miltenyi Biotec Major Business
Table 41. Miltenyi Biotec PECAM-1 Antibody Product and Services
Table 42. Miltenyi Biotec PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Bio-Rad Basic Information, Manufacturing Base and Competitors
Table 44. Bio-Rad Major Business
Table 45. Bio-Rad PECAM-1 Antibody Product and Services
Table 46. Bio-Rad PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. LifeSpan Biosciences Basic Information, Manufacturing Base and Competitors
Table 48. LifeSpan Biosciences Major Business
Table 49. LifeSpan Biosciences PECAM-1 Antibody Product and Services
Table 50. LifeSpan Biosciences PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Abnova Basic Information, Manufacturing Base and Competitors
Table 52. Abnova Major Business
Table 53. Abnova PECAM-1 Antibody Product and Services
Table 54. Abnova PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. OriGene Basic Information, Manufacturing Base and Competitors
Table 56. OriGene Major Business
Table 57. OriGene PECAM-1 Antibody Product and Services
Table 58. OriGene PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. SICGEN Basic Information, Manufacturing Base and Competitors
Table 60. SICGEN Major Business
Table 61. SICGEN PECAM-1 Antibody Product and Services
Table 62. SICGEN PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. YO Proteins Basic Information, Manufacturing Base and Competitors
Table 64. YO Proteins Major Business
Table 65. YO Proteins PECAM-1 Antibody Product and Services
Table 66. YO Proteins PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Enzo Life Sciences Basic Information, Manufacturing Base and Competitors
Table 68. Enzo Life Sciences Major Business
Table 69. Enzo Life Sciences PECAM-1 Antibody Product and Services
Table 70. Enzo Life Sciences PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Boster Basic Information, Manufacturing Base and Competitors
Table 72. Boster Major Business
Table 73. Boster PECAM-1 Antibody Product and Services
Table 74. Boster PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Abeomics Basic Information, Manufacturing Base and Competitors
Table 76. Abeomics Major Business
Table 77. Abeomics PECAM-1 Antibody Product and Services
Table 78. Abeomics PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Rockland Immunochemicals Basic Information, Manufacturing Base and Competitors
Table 80. Rockland Immunochemicals Major Business
Table 81. Rockland Immunochemicals PECAM-1 Antibody Product and Services
Table 82. Rockland Immunochemicals PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Bon Opus Biosciences Basic Information, Manufacturing Base and Competitors
Table 84. Bon Opus Biosciences Major Business
Table 85. Bon Opus Biosciences PECAM-1 Antibody Product and Services
Table 86. Bon Opus Biosciences PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. Creative Biomart Basic Information, Manufacturing Base and Competitors
Table 88. Creative Biomart Major Business
Table 89. Creative Biomart PECAM-1 Antibody Product and Services
Table 90. Creative Biomart PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. US Biological Basic Information, Manufacturing Base and Competitors
Table 92. US Biological Major Business
Table 93. US Biological PECAM-1 Antibody Product and Services
Table 94. US Biological PECAM-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 95. Global PECAM-1 Antibody Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kg)
Table 96. Global PECAM-1 Antibody Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 97. Market Position of Manufacturers in PECAM-1 Antibody, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 98. Global PECAM-1 Antibody Production Capacity by Company, (Kg): 2020 VS 2021
Table 99. Head Office and PECAM-1 Antibody Production Site of Key Manufacturer
Table 100. PECAM-1 Antibody New Entrant and Capacity Expansion Plans
Table 101. PECAM-1 Antibody Mergers & Acquisitions in the Past Five Years
Table 102. Global PECAM-1 Antibody Sales by Region (2017-2022) & (Kg)
Table 103. Global PECAM-1 Antibody Sales by Region (2023-2028) & (Kg)
Table 104. Global PECAM-1 Antibody Revenue by Region (2017-2022) & (USD Million)
Table 105. Global PECAM-1 Antibody Revenue by Region (2023-2028) & (USD Million)
Table 106. Global PECAM-1 Antibody Sales by Type (2017-2022) & (Kg)
Table 107. Global PECAM-1 Antibody Sales by Type (2023-2028) & (Kg)
Table 108. Global PECAM-1 Antibody Revenue by Type (2017-2022) & (USD Million)
Table 109. Global PECAM-1 Antibody Revenue by Type (2023-2028) & (USD Million)
Table 110. Global PECAM-1 Antibody Price by Type (2017-2022) & (USD/g)
Table 111. Global PECAM-1 Antibody Price by Type (2023-2028) & (USD/g)
Table 112. Global PECAM-1 Antibody Sales by Application (2017-2022) & (Kg)
Table 113. Global PECAM-1 Antibody Sales by Application (2023-2028) & (Kg)
Table 114. Global PECAM-1 Antibody Revenue by Application (2017-2022) & (USD Million)
Table 115. Global PECAM-1 Antibody Revenue by Application (2023-2028) & (USD Million)
Table 116. Global PECAM-1 Antibody Price by Application (2017-2022) & (USD/g)
Table 117. Global PECAM-1 Antibody Price by Application (2023-2028) & (USD/g)
Table 118. North America PECAM-1 Antibody Sales by Country (2017-2022) & (Kg)
Table 119. North America PECAM-1 Antibody Sales by Country (2023-2028) & (Kg)
Table 120. North America PECAM-1 Antibody Revenue by Country (2017-2022) & (USD Million)
Table 121. North America PECAM-1 Antibody Revenue by Country (2023-2028) & (USD Million)
Table 122. North America PECAM-1 Antibody Sales by Type (2017-2022) & (Kg)
Table 123. North America PECAM-1 Antibody Sales by Type (2023-2028) & (Kg)
Table 124. North America PECAM-1 Antibody Sales by Application (2017-2022) & (Kg)
Table 125. North America PECAM-1 Antibody Sales by Application (2023-2028) & (Kg)
Table 126. Europe PECAM-1 Antibody Sales by Country (2017-2022) & (Kg)
Table 127. Europe PECAM-1 Antibody Sales by Country (2023-2028) & (Kg)
Table 128. Europe PECAM-1 Antibody Revenue by Country (2017-2022) & (USD Million)
Table 129. Europe PECAM-1 Antibody Revenue by Country (2023-2028) & (USD Million)
Table 130. Europe PECAM-1 Antibody Sales by Type (2017-2022) & (Kg)
Table 131. Europe PECAM-1 Antibody Sales by Type (2023-2028) & (Kg)
Table 132. Europe PECAM-1 Antibody Sales by Application (2017-2022) & (Kg)
Table 133. Europe PECAM-1 Antibody Sales by Application (2023-2028) & (Kg)
Table 134. Asia-Pacific PECAM-1 Antibody Sales by Region (2017-2022) & (Kg)
Table 135. Asia-Pacific PECAM-1 Antibody Sales by Region (2023-2028) & (Kg)
Table 136. Asia-Pacific PECAM-1 Antibody Revenue by Region (2017-2022) & (USD Million)
Table 137. Asia-Pacific PECAM-1 Antibody Revenue by Region (2023-2028) & (USD Million)
Table 138. Asia-Pacific PECAM-1 Antibody Sales by Type (2017-2022) & (Kg)
Table 139. Asia-Pacific PECAM-1 Antibody Sales by Type (2023-2028) & (Kg)
Table 140. Asia-Pacific PECAM-1 Antibody Sales by Application (2017-2022) & (Kg)
Table 141. Asia-Pacific PECAM-1 Antibody Sales by Application (2023-2028) & (Kg)
Table 142. South America PECAM-1 Antibody Sales by Country (2017-2022) & (Kg)
Table 143. South America PECAM-1 Antibody Sales by Country (2023-2028) & (Kg)
Table 144. South America PECAM-1 Antibody Revenue by Country (2017-2022) & (USD Million)
Table 145. South America PECAM-1 Antibody Revenue by Country (2023-2028) & (USD Million)
Table 146. South America PECAM-1 Antibody Sales by Type (2017-2022) & (Kg)
Table 147. South America PECAM-1 Antibody Sales by Type (2023-2028) & (Kg)
Table 148. South America PECAM-1 Antibody Sales by Application (2017-2022) & (Kg)
Table 149. South America PECAM-1 Antibody Sales by Application (2023-2028) & (Kg)
Table 150. Middle East & Africa PECAM-1 Antibody Sales by Region (2017-2022) & (Kg)
Table 151. Middle East & Africa PECAM-1 Antibody Sales by Region (2023-2028) & (Kg)
Table 152. Middle East & Africa PECAM-1 Antibody Revenue by Region (2017-2022) & (USD Million)
Table 153. Middle East & Africa PECAM-1 Antibody Revenue by Region (2023-2028) & (USD Million)
Table 154. Middle East & Africa PECAM-1 Antibody Sales by Type (2017-2022) & (Kg)
Table 155. Middle East & Africa PECAM-1 Antibody Sales by Type (2023-2028) & (Kg)
Table 156. Middle East & Africa PECAM-1 Antibody Sales by Application (2017-2022) & (Kg)
Table 157. Middle East & Africa PECAM-1 Antibody Sales by Application (2023-2028) & (Kg)
Table 158. PECAM-1 Antibody Raw Material
Table 159. Key Manufacturers of PECAM-1 Antibody Raw Materials
Table 160. Direct Channel Pros & Cons
Table 161. Indirect Channel Pros & Cons
Table 162. PECAM-1 Antibody Typical Distributors
Table 163. PECAM-1 Antibody Typical Customers
List of Figures
Figure 1. PECAM-1 Antibody Picture
Figure 2. Global PECAM-1 Antibody Revenue Market Share by Type in 2021
Figure 3. Mouse
Figure 4. Rabbit
Figure 5. Others
Figure 6. Global PECAM-1 Antibody Revenue Market Share by Application in 2021
Figure 7. Laboratory
Figure 8. Hospital
Figure 9. Others
Figure 10. Global PECAM-1 Antibody Revenue, (USD Million) & (Kg): 2017 & 2021 & 2028
Figure 11. Global PECAM-1 Antibody Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global PECAM-1 Antibody Sales (2017-2028) & (Kg)
Figure 13. Global PECAM-1 Antibody Price (2017-2028) & (USD/g)
Figure 14. Global PECAM-1 Antibody Production Capacity (2017-2028) & (Kg)
Figure 15. Global PECAM-1 Antibody Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. PECAM-1 Antibody Market Drivers
Figure 17. PECAM-1 Antibody Market Restraints
Figure 18. PECAM-1 Antibody Market Trends
Figure 19. Global PECAM-1 Antibody Sales Market Share by Manufacturer in 2021
Figure 20. Global PECAM-1 Antibody Revenue Market Share by Manufacturer in 2021
Figure 21. PECAM-1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 PECAM-1 Antibody Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 PECAM-1 Antibody Manufacturer (Revenue) Market Share in 2021
Figure 24. Global PECAM-1 Antibody Sales Market Share by Region (2017-2028)
Figure 25. Global PECAM-1 Antibody Revenue Market Share by Region (2017-2028)
Figure 26. North America PECAM-1 Antibody Revenue (2017-2028) & (USD Million)
Figure 27. Europe PECAM-1 Antibody Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific PECAM-1 Antibody Revenue (2017-2028) & (USD Million)
Figure 29. South America PECAM-1 Antibody Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa PECAM-1 Antibody Revenue (2017-2028) & (USD Million)
Figure 31. Global PECAM-1 Antibody Sales Market Share by Type (2017-2028)
Figure 32. Global PECAM-1 Antibody Revenue Market Share by Type (2017-2028)
Figure 33. Global PECAM-1 Antibody Price by Type (2017-2028) & (USD/g)
Figure 34. Global PECAM-1 Antibody Sales Market Share by Application (2017-2028)
Figure 35. Global PECAM-1 Antibody Revenue Market Share by Application (2017-2028)
Figure 36. Global PECAM-1 Antibody Price by Application (2017-2028) & (USD/g)
Figure 37. North America PECAM-1 Antibody Sales Market Share by Type (2017-2028)
Figure 38. North America PECAM-1 Antibody Sales Market Share by Application (2017-2028)
Figure 39. North America PECAM-1 Antibody Sales Market Share by Country (2017-2028)
Figure 40. North America PECAM-1 Antibody Revenue Market Share by Country (2017-2028)
Figure 41. United States PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe PECAM-1 Antibody Sales Market Share by Type (2017-2028)
Figure 45. Europe PECAM-1 Antibody Sales Market Share by Application (2017-2028)
Figure 46. Europe PECAM-1 Antibody Sales Market Share by Country (2017-2028)
Figure 47. Europe PECAM-1 Antibody Revenue Market Share by Country (2017-2028)
Figure 48. Germany PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific PECAM-1 Antibody Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific PECAM-1 Antibody Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific PECAM-1 Antibody Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific PECAM-1 Antibody Revenue Market Share by Region (2017-2028)
Figure 57. China PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America PECAM-1 Antibody Sales Market Share by Type (2017-2028)
Figure 64. South America PECAM-1 Antibody Sales Market Share by Application (2017-2028)
Figure 65. South America PECAM-1 Antibody Sales Market Share by Country (2017-2028)
Figure 66. South America PECAM-1 Antibody Revenue Market Share by Country (2017-2028)
Figure 67. Brazil PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa PECAM-1 Antibody Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa PECAM-1 Antibody Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa PECAM-1 Antibody Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa PECAM-1 Antibody Revenue Market Share by Region (2017-2028)
Figure 73. Turkey PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa PECAM-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of PECAM-1 Antibody in 2021
Figure 78. Manufacturing Process Analysis of PECAM-1 Antibody
Figure 79. PECAM-1 Antibody Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のPECAM-1抗体市場2022年：ネズミ、ウナギ、その他(Global PECAM-1 Antibody Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のVEGF抗体市場2022年：ウサギ、ネズミ、ヤギ、その他
  • 世界のアディポネクチン抗体市場2022年：うさぎ、ねずみ、鶏、犬、その他
  • 世界のPECAM-1タンパク質市場2022年：ネズミ、ウナギ、その他
  • 世界のヒトVEGF抗体市場2022年：ウサギ、ネズミ、ヤギ、その他
  • 世界のPD-1＆PD-L1モノクローナル抗体市場2022年：PD-1、 PD-L1